Molecular mechanism for nobiletin to enhance ABCA1/G1 expression in mouse macrophages

Tomoe Tsuboi1, Rui Lu1, Takayuki Yonezawa2

  • 1Bioscience and Biotechnology, Chubu University, Kasaugai, Aichi, 487-8501, Japan.

Atherosclerosis
|February 17, 2020
PubMed
Abstract

Insights

Nobiletin (NOB) activates AMPK and LXRα to boost ABCA1/ABCG1 expression, enhancing HDL biogenesis. An LXRα-PPARγ loop further amplifies these cholesterol-regulating signals.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Nobiletin (NOB), a citrus peel compound, shows potential against metabolic diseases.
  • NOB's reported effects on AMPK, SREBP1c, PPARα, and PPARγ lack a clear molecular mechanism.
  • Understanding NOB's role in HDL biogenesis via ABCA1 and ABCG1 is crucial.

Purpose of the Study:

  • To investigate the molecular mechanism of Nobiletin (NOB) in regulating HDL biogenesis.
  • To elucidate NOB's effect on ABCA1 and ABCG1 expression in macrophages.
  • To determine the signaling pathways involved in NOB-mediated cholesterol regulation.

Main Methods:

  • Utilized mouse macrophages (J774.1) to study NOB's effects.
  • Assessed mRNA and protein levels of ABCA1, ABCG1, PPARγ, LXRα, CD36, and LPL1.
  • Investigated the roles of AMPK, LXRα, and PPARγ using inhibitors and siRNA.

Main Results:

  • NOB increased ABCA1/G1 mRNA and protein levels, promoting cholesterol release.
  • NOB upregulated LXRα and PPARγ, but not PPARα.
  • NOB-induced ABCA1/G1 expression was dependent on AMPK, LXRα, and PPARγ signaling, involving an LXRα-PPARγ feedback loop.

Conclusions:

  • NOB activates AMPK, which then promotes LXRα expression.
  • LXRα and PPARγ form a loop that amplifies ABCA1 and ABCG1 expression.
  • This pathway highlights NOB's potential in modulating HDL biogenesis and cholesterol homeostasis.

Related Concept Videos